Hyperfine, Inc. to Participate in Upcoming Investor Conferences - Candlesense

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop¼ system—today announced their schedule for upcoming investor conferences. Hyperfine will discuss with investors recently announced milestones and growth catalysts, including its two major new technology clearances, commercial launch and market feedback